General form of registration statement for all companies including face-amount certificate companies
Cover
Document and Entity Information
Financial Statements
BALANCE SHEETS
BALANCE SHEETS (Parenthetical)
STATEMENTS OF OPERATIONS
STATEMENTS OF STOCKHOLDERS' EQUITY
STATEMENTS OF CASH FLOWS
Notes to Financial Statements
Organization and Description of Business
Significant Accounting Policies
License, Clinical Trial and Sponsored Research Agreements
Related Party Agreements
Property, Plant and Equipment, and Fixed Assets - Construction in Process
Accounts Payable and Accrued Expenses
Commitments and Contingencies
Notes Payable
Stockholders' Equity
Income Taxes
Subsequent Events
Accounting Policies
Significant Accounting Policies (Policies)
Notes Tables
Significant Accounting Policies (Tables)
License, Clinical Trial and Sponsored Research Agreements (Tables)
Property, Plant and Equipment, and Fixed Assets - Construction in Process (Tables)
Accounts Payable and Accrued Expenses (Tables)
Commitments and Contingencies (Tables)
Notes Payable (Tables)
Stockholders' Equity (Tables)
Income Taxes (Tables)
Notes Details
Organization and Description of Business (Details)
Significant Accounting Policies (Narrative) (Details)
Significant Accounting Policies (Schedule of Potentially Dilutive Securities) (Details)
License, Clinical Trial and Sponsored Research Agreements (License Agreements) (Details)
License, Clinical Trial and Sponsored Research Agreements (City of Hope - Sponsored Research and Clinical Trial Agreements) (Narrative) (Details)
License, Clinical Trial and Sponsored Research Agreements (City of Hope - Licenses) (Narrative) (Details)
License, Clinical Trial and Sponsored Research Agreements (Other - Sponsored Research and Clinical Trial Agreements) (Narrative) (Details)
Related Party Agreements (Narrative) (Details)
Property, Plant and Equipment, and Fixed Assets - Construction in Process (Narrative) (Details)
Property, Plant and Equipment, and Fixed Assets - Construction in Process (Details)
Accounts Payable and Accrued Expenses (Schedule of Accounts Payable and Accrued Expenses) (Details)
Commitments and Contingencies (Narrative) (Details)
Commitments and Contingencies (Schedule of Operating Leases) (Details)
Commitments and Contingencies (Cash Flows) (Details)
Commitments and Contingencies (Maturities of Operating Leases) (Details)
Notes Payable (Narrative) (Details)
Notes Payable - Interest Expense (Details)
Stockholders' Equity (Registration Statements and At-the-Market Offering) (Details)
Stockholders' Equity - May 2024 Equity Offering (Details)
Stockholders' Equity - June 2024 Registered Direct Offering (Details)
Stockholders' Equity (Equity Incentive Plans and Employee Stock Purchase Plan) (Details)
Stockholders' Equity (Stock Option Activities) (Details)
Stockholders' Equity (Restricted Stock or Restricted Units Awards) (Details)
Stockholders' Equity (Stock-based Compensation Expense) (Details)
Stockholders' Equity (Warrants Activity) (Details)
Income Taxes (Narrative) (Details)
Income Taxes (Effective Income Tax Rate Reconciliation) (Details)
Income Taxes (Schedule of Deferred Tax Assets) (Details)
Subsequent Events (Details)
Uncategorized
Balance Sheets (Unaudited)
Balance Sheets (Unaudited) (Parenthetical)
Statements of Operations (Unaudited)
Statements of Stockholders' Equity (Unaudited)
Statements of Cash Flows (Unaudited)
Statements of Cash Flows - Non-Cash Activities (Unaudited) (Parenthetical)
Organization, Description of Business and Liquidity and Capital Resources
Significant Accounting Policies
Clinical Trial and Sponsored Research Agreements
Related Party Agreements
Assets Purchase Agreements
Property, Plant and Equipment, and Asset Impairment
Accounts Payable and Accrued Expenses
Notes Payable
Stockholders' Equity
Net Loss per Share
Income Taxes
Commitments and Contingencies
Subsequent Events
Significant Accounting Policies (Policies)
Significant Accounting Policies (Tables)
Clinical Trial and Sponsored Research Agreements (Tables)
Property, Plant and Equipment, and Asset Impairment (Tables)
Accounts Payable and Accrued Expenses (Tables)
Notes Payable (Tables)
Stockholders' Equity (Tables)
Net Loss per Share (Tables)
Commitments and Contingencies (Tables)
Organization, Description of Business and Liquidity and Capital Resources (Details)
Significant Accounting Policies (Cash, Cash Equivalents, and Restricted Cash) (Details)
Clinical Trial and Sponsored Research Agreements (Details)
Clinical Trial and Sponsored Research Agreements (City of Hope - Sponsored Research and Clinical Trial Agreements) (Narrative) (Details)
Related Party Agreements (Narrative) (Details)
Assets Purchase Agreements (Details)
Property, Plant and Equipment, and Asset Impairment (Schedule of Property, Plant and Equipment) (Details)
Property, Plant and Equipment, and Asset Impairment (Narrative) (Details)
Accounts Payable and Accrued Expenses (Schedule of Accounts Payable and Accrued Expenses) (Details)
Notes Payable (Narrative) (Details)
Notes Payable - Interest Expense (Details)
Stockholders' Equity (Registration Statements and At-the-Market Offering) (Details)
Stockholders' Equity - May 2024 Equity Offering (Details)
Stockholders' Equity - June 2024 Registered Direct Offering (Details)
Stockholders' Equity (Equity Incentive Plans and Employee Stock Purchase Plan) (Details)
Stockholders' Equity (Stock Option Activities) (Details)
Stockholders' Equity (Restricted Stock or Restricted Units Awards) (Details)
Stockholders' Equity (Stock-based Compensation Expense) (Details)
Stockholders' Equity (Warrants Activity) (Details)
Net Loss per Share (Potentially Dilutive Securities) (Details)
Commitments and Contingencies (Narrative) (Details)
Commitments and Contingencies (Schedule of Operating Leases) (Details)
Commitments and Contingencies (Cash Flows) (Details)
Commitments and Contingencies (Maturities of Operating Leases) (Details)
Subsequent Events (Details)
STATEMENTS OF CASH FLOWS
403 Forbidden
Forbidden
You don't have permission to access this resource.